reported that METTL3 was downregulated in CML cells, resulting in a decrease in the protein level of nuclear enriched abundant transcript 1 (NEAT1) (70). This evidence concerns the gene NEAT1 and chronic myelogenous leukemia, BCR-ABL1 positive.